Skip to main content
Signal8
Launch Terminal
Lu Yufang profile photo

Yufang Lu

CIK: 0002079960

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ImageneBio, Inc. logo
IMA

ImageneBio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • ImageneBio, Inc. logo
    IMA

    ImageneBio, Inc.

    Jul 25, 2025
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    38.1K shares-
  • ImageneBio, Inc. logo
    IMA

    ImageneBio, Inc.

    Jul 25, 2025
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    27.5K shares-
  • ImageneBio, Inc. logo
    IMA

    ImageneBio, Inc.

    Jul 25, 2025
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    4.6K shares-
  • ImageneBio, Inc. logo
    IMA

    ImageneBio, Inc.

    Jul 25, 2025
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    6.1K shares-

1-4 of 4

About Lu Yufang

Lu Yufang (SEC CIK 0002079960) files insider reports with the SEC as Chief Medical Officer of ImageneBio, Inc. (IMA).

Signal8 holds 2 ownership filings by Lu Yufang (1 Form 3, 1 Form 4), filed on Aug 7, 2025. Those filings report 4 transactions, the latest on Jul 25, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Lu Yufang's filings is in SAN DIEGO, CA.

Recent filings by Lu Yufang

  • Jul 25, 2025: Grants or awards of IMA derivative securities (4 lines, Form 4, code A).

Other insiders filing for ImageneBio, Inc. (IMA)

How to read Form 4 transaction codes